Recently, GSTZ1‐1 was reported to be downregulated in HCC and upregulated in breast cancer (Jahn et al, 2016), indicating that dysregulation of GSTZ1‐1 may be involved in the tumorigenesis in humans. The gene discussed is GSTZ1; the disease is breast carcinoma.